Enable Biosciences Publishes Study Revealing ADAP Technology's Improved Accuracy in T1D Risk Prediction
/PRNewswire/ -- Enable Biosciences Inc. has shared compelling new data on the performance of its Antibody Detection by Agglutination-PCR (ADAP) technology in...
Source: prnewswire.com